Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates
Bizuayehu, HM
Dadi, AF
Ahmed, KY
Tegegne, TK
Hassen, TA
Kibret, GD
Ketema, DB
Bore, MG
Thapa, S
Odo, DB
Kassa, ZY
Shifti, DM
Amsalu, E
Sarich, P
Venchiarutti, RL
Melaku, YA
Kibret, KT
- Publisher:
- Wiley
- Publication Type:
- Journal Article
- Citation:
- Cancer, 2024, 130, (21), pp. 3708-3723
- Issue Date:
- 2024-11-01
Recently Added
Filename | Description | Size | |||
---|---|---|---|---|---|
journal.pone.0314882.pdf | Published version | 2.96 MB | Adobe PDF |
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is new to OPUS and is not currently available.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Bizuayehu, HM | |
dc.contributor.author | Dadi, AF | |
dc.contributor.author | Ahmed, KY | |
dc.contributor.author | Tegegne, TK | |
dc.contributor.author | Hassen, TA | |
dc.contributor.author | Kibret, GD | |
dc.contributor.author | Ketema, DB | |
dc.contributor.author | Bore, MG | |
dc.contributor.author | Thapa, S | |
dc.contributor.author | Odo, DB | |
dc.contributor.author | Kassa, ZY | |
dc.contributor.author | Shifti, DM | |
dc.contributor.author | Amsalu, E | |
dc.contributor.author | Sarich, P | |
dc.contributor.author | Venchiarutti, RL | |
dc.contributor.author | Melaku, YA | |
dc.contributor.author | Kibret, KT | |
dc.date.accessioned | 2025-03-31T01:29:14Z | |
dc.date.available | 2024-06-07 | |
dc.date.available | 2025-03-31T01:29:14Z | |
dc.date.issued | 2024-11-01 | |
dc.identifier.citation | Cancer, 2024, 130, (21), pp. 3708-3723 | |
dc.identifier.issn | 1097-0142 | |
dc.identifier.issn | 1097-0142 | |
dc.identifier.uri | http://hdl.handle.net/10453/186332 | |
dc.description.abstract | BACKGROUND Men exhibit higher prevalence of modifiable risk factors, such as smoking and alcohol consumption, leading to greater cancer incidence and lower survival rates. Comprehensive evidence on global cancer burden among men, including disparities by age group and country, is sparse. To address this, the authors analyzed 30 cancer types among men in 2022, with projections estimated for 2050. METHODS The 2022 GLOBOCAN estimates were used to describe cancer statistics for men in 185 countries/territories worldwide. Mortality-to-incidence ratios (MIRs) were calculated by dividing age-standardized mortality rates by incidence rates. RESULTS In 2022, a high MIR (indicating poor survival) was observed among older men (aged 65 years and older 61 ) for rare cancer types (pancreatic cancer, 91 ) and in countries with low a Human Development Index (HDI 74 ). Between 2022 and 2050, cancer cases are projected to increase from 10.3 million to 19 million ( 84 ). Deaths are projected to increase from 5.4 million to 10.5 million ( 93 ), with a greater than two-fold increase among men aged 65 years and older ( 117 ) and for low-HDI and medium-HDI countries/territories ( 160 ). Cancer cases and deaths are projected to increase among working-age groups ( 39 ) and very-high-HDI countries/territories ( 50 ). CONCLUSIONS Substantial disparities in cancer cases and deaths were observed among men in 2022, and these are projected to widen by 2050. Strengthening health infrastructure, enhancing workforce quality and access, fostering national and international collaborations, and promoting universal health coverage are crucial to reducing cancer disparities and ensuring cancer equity among men globally. | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Wiley | |
dc.relation.ispartof | Cancer | |
dc.relation.isbasedon | 10.1002/cncr.35458 | |
dc.rights | info:eu-repo/semantics/restrictedAccess | |
dc.subject | 1112 Oncology and Carcinogenesis, 1117 Public Health and Health Services | |
dc.subject.classification | Oncology & Carcinogenesis | |
dc.subject.classification | 3211 Oncology and carcinogenesis | |
dc.subject.classification | 4206 Public health | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Global Health | |
dc.subject.mesh | Incidence | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Young Adult | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Survival Rate | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Incidence | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Survival Rate | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Male | |
dc.subject.mesh | Young Adult | |
dc.subject.mesh | Global Health | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Male | |
dc.subject.mesh | Neoplasms | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Middle Aged | |
dc.subject.mesh | Global Health | |
dc.subject.mesh | Incidence | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Young Adult | |
dc.subject.mesh | Aged, 80 and over | |
dc.subject.mesh | Risk Factors | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Survival Rate | |
dc.title | Burden of 30 cancers among men: Global statistics in 2022 and projections for 2050 using population‐based estimates | |
dc.type | Journal Article | |
utslib.citation.volume | 130 | |
utslib.location.activity | United States | |
utslib.for | 1112 Oncology and Carcinogenesis | |
utslib.for | 1117 Public Health and Health Services | |
pubs.organisational-group | University of Technology Sydney | |
pubs.organisational-group | University of Technology Sydney/Faculty of Health | |
utslib.copyright.status | recently_added | * |
pubs.consider-herdc | true | |
dc.date.updated | 2025-03-31T01:29:09Z | |
pubs.issue | 21 | |
pubs.publication-status | Published | |
pubs.volume | 130 | |
utslib.citation.issue | 21 |
Abstract:
BACKGROUND Men exhibit higher prevalence of modifiable risk factors, such as smoking and alcohol consumption, leading to greater cancer incidence and lower survival rates. Comprehensive evidence on global cancer burden among men, including disparities by age group and country, is sparse. To address this, the authors analyzed 30 cancer types among men in 2022, with projections estimated for 2050. METHODS The 2022 GLOBOCAN estimates were used to describe cancer statistics for men in 185 countries/territories worldwide. Mortality-to-incidence ratios (MIRs) were calculated by dividing age-standardized mortality rates by incidence rates. RESULTS In 2022, a high MIR (indicating poor survival) was observed among older men (aged 65 years and older 61 ) for rare cancer types (pancreatic cancer, 91 ) and in countries with low a Human Development Index (HDI 74 ). Between 2022 and 2050, cancer cases are projected to increase from 10.3 million to 19 million ( 84 ). Deaths are projected to increase from 5.4 million to 10.5 million ( 93 ), with a greater than two-fold increase among men aged 65 years and older ( 117 ) and for low-HDI and medium-HDI countries/territories ( 160 ). Cancer cases and deaths are projected to increase among working-age groups ( 39 ) and very-high-HDI countries/territories ( 50 ). CONCLUSIONS Substantial disparities in cancer cases and deaths were observed among men in 2022, and these are projected to widen by 2050. Strengthening health infrastructure, enhancing workforce quality and access, fostering national and international collaborations, and promoting universal health coverage are crucial to reducing cancer disparities and ensuring cancer equity among men globally.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph